From a TA perspective there's little to say about this stock, especially long term. Clinical-stage bios can either shoot to the moon or head to zero at the drop of a hat, but with no earnings here in the next (???) years, there's just no basis to predict. Weekly chart shows a moderate bull flag dating back to 2015, which if there were real earnings to report periodically, could indicate a potential bounce above the 3.50 to 4.00 zone, but I just don't see it here. Been avoiding for quite a while now.
News 
Market Data 
Discover 
